Annual report pursuant to Section 13 and 15(d)

Accrued Expenses

Accrued Expenses

12 Months Ended

Dec. 31, 2023

Payables and Accruals [Abstract]

Accrued Expenses

Note 7 – Accrued Expenses

Accrued expenses at December 31, 2023 and 2022 consisted of the following:

Schedule of Accrued Expenses

	December 31, 2023			December 31, 2022
Accrued payroll and related liabilities	$	8,338,517		$	8,433,076
HHS Provider Relief Funds		144,805			552,099
Accrued interest		6,663,561			5,732,306
Accrued legal expenses and settlements		1,797,170			534,550
Medicare cost report settlement reserves		2,264,847			2,101,837
Other accrued expenses		2,383,068			2,030,935
Total accrued expenses		21,591,968			19,384,803
Less current portion of accrued expenses		(15,399,268	)		(19,384,803	)
Accrued expenses long-term	$	6,192,700		$	-

Accrued payroll and related liabilities included approximately $7.3 million and $7.0 million for accrued past due payroll taxes and associated penalties and interest as of December 31, 2023 and 2022, respectively.

As of December 31, 2023 and 2022, the Company has accrued approximately $0.1 million and $0.6 million, respectively, of HHS Provider Relief Funds. These funds are more fully discussed in Notes 1 and 14.

As of December 31, 2023, accrued expenses long-term consisted of $6.2 million of accrued interest associated with debentures as more fully discussed in Note 8.